1. Home
  2. FIGS vs ENOV Comparison

FIGS vs ENOV Comparison

Compare FIGS & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FIGS Inc.

FIGS

FIGS Inc.

HOLD

Current Price

$12.40

Market Cap

2.0B

ML Signal

HOLD

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$25.56

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIGS
ENOV
Founded
2013
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Fluid Controls
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
FIGS
ENOV
Price
$12.40
$25.56
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$10.10
$48.13
AVG Volume (30 Days)
2.7M
1.1M
Earning Date
01-01-0001
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$419,591,000.00
N/A
Revenue This Year
$9.18
$9.18
Revenue Next Year
$4.95
$4.69
P/E Ratio
$121.78
N/A
Revenue Growth
59.47
N/A
52 Week Low
$3.57
$21.00
52 Week High
$12.50
$40.70

Technical Indicators

Market Signals
Indicator
FIGS
ENOV
Relative Strength Index (RSI) 69.01 62.83
Support Level $11.18 $21.30
Resistance Level N/A $32.29
Average True Range (ATR) 0.53 1.06
MACD 0.16 0.41
Stochastic Oscillator 93.95 100.00

Price Performance

Historical Comparison
FIGS
ENOV

About FIGS FIGS Inc.

FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: